A 28-year-old woman with a 15-year history of focal impaired-awareness seizures presents with recurrent episodes of epigastric rising aura, déjà vu, and oral automatisms followed by post-ictal confusion. She has failed trials of levetiracetam, lamotrigine, and lacosamide. High-resolution 3T MRI with epilepsy protocol shows the finding marked **A** in the diagram. Which of the following statements best characterizes the pathological substrate underlying her seizure disorder?

Question

Accepted Answer

B. Selective neuronal loss in CA1 (Sommer sector) and CA3/CA4 regions with reactive gliosis and mossy fiber sprouting, most commonly following an initial precipitating injury in childhood. ## Why option 1 is right

The finding marked **A** — hippocampal atrophy with T2 hyperintensity — is the pathognomonic imaging signature of mesial temporal sclerosis (MTS), also called hippocampal sclerosis. This is the most common pathological substrate of temporal lobe epilepsy and the most common cause of drug-resistant focal epilepsy in adults. The underlying pathology shows selective neuronal loss in the CA1 (Sommer sector) and CA3/CA4 (endfolium) regions with relative sparing of CA2, accompanied by reactive gliosis and mossy fiber sprouting in the dentate gyrus. Most patients have a history of an initial precipitating injury (prolonged febrile seizures, status epilepticus, CNS infection, or trauma) in childhood, followed by a latent period and emergence of focal impaired-awareness seizures in adolescence/young adulthood — exactly as described in this patient. The clinical semiology (epigastric aura, déjà vu, oral automatisms, post-ictal confusion) and drug resistance are classic for MTS. High-resolution 3T MRI with epilepsy protocol is the imaging gold standard for diagnosis (ILAE Guidelines; Wiebe NEJM 2001).

## Why each distractor is wrong

- **Option 2 (bilateral basal ganglia calcification)**: This corresponds to finding **B** in the diagram and is not the pathological substrate of MTS. Basal ganglia calcification is seen in conditions like Fahr disease, hypoparathyroidism, and progressive myoclonic epilepsies — not temporal lobe epilepsy with the clinical phenotype described.

- **Option 3 (diffuse cortical laminar necrosis)**: This corresponds to finding **D** and is characteristic of post-traumatic epilepsy from penetrating head injury or severe cortical injury, not MTS. While trauma can be an initial precipitating injury for MTS, the pathology evolves into selective hippocampal neuronal loss, not diffuse cortical necrosis.

- **Option 4 (cerebellar Purkinje cell loss)**: This corresponds to finding **C** and is seen in progressive ataxia-associated seizure syndromes and hereditary cerebellar degenerations, not MTS. Cerebellar atrophy is not part of the MTS pathological substrate.

**High-Yield:** MTS = selective CA1/CA3/CA4 neuronal loss + gliosis + mossy fiber sprouting; most common cause of drug-resistant focal epilepsy; anterior temporal lobectomy achieves seizure freedom in 60–80% vs. 8% on continued medical therapy.

[cite: ILAE Guidelines; Wiebe NEJM 2001 RCT on temporal lobectomy]

Answer

A. Bilateral basal ganglia calcification with secondary degeneration of thalamic relay nuclei, typically associated with progressive myoclonic epilepsy

Answer

C. Cerebellar Purkinje cell loss with secondary atrophy of dentate nucleus, seen in progressive ataxia-associated seizure syndromes

Answer

D. Diffuse cortical laminar necrosis with preserved hippocampal architecture, characteristic of post-traumatic epilepsy from penetrating head injury

Explanation

Why option 1 is right

Why each distractor is wrong

Practice similar questions